로딩 중…
지수 로딩 중…
Gossamer Bio, Inc.
GOSS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$0.17+0.24%
2026-08-03
Financials
Valuation Metrics
Gossamer Bio, Inc.'s Market Cap is $40M. At end of 2025 it was $702M. Ranked #3101 of 3,112 in US market (top 100%), #1435 of 1,445 on NASDAQ (top 99%), #269 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 100%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $40M | US#3,101/3,112 Sec#269/269 |
| Revenue | $56M | US#2,854/3,112 Sec#153/269 |
| Net Income | $-180M | US—/3,112 Sec—/269 |
| Total Assets | $129M | US#3,020/3,112 Sec#260/269 |
| Net Assets | $29M | US#2,965/3,112 Sec#249/269 |
| Value | ||
| P/B | 1.35x | US#685/3,112 Sec#31/269 |
| P/S | 0.72x | US#435/3,112 Sec#9/269 |
| FCF Yield | -427.13% | US—/3,112 Sec—/269 |
| Profitability | ||
| Op. Margin | -321.92% | US#2,880/3,112 Sec#152/269 |
| Revenue Growth | 71.45% | US#202/3,112 Sec#41/269 |
| Financial Health | ||
| Debt Ratio | 984.61% | US#2,761/3,112 Sec#243/269 |
| Total Debt | $203M | US#2,186/3,112 Sec#94/269 |
| FCF | $-170M | US#2,701/3,112 Sec#200/269 |
| Cash | $41M | US#2,660/3,112 Sec#235/269 |
| Current Ratio | 2.20x | US#1,132/3,112 Sec#218/269 |
| Performance | ||
| 1Y Return | -91.51% | US#3,127/3,112 Sec#269/269 |
| 1M Return | -1.91% | US#1,902/3,112 Sec#98/269 |
| From 52W High | -95.61% | US#3,121/3,112 Sec#272/269 |
| 1Y MDD | -96.41% | US#3,117/3,112 Sec#272/269 |
| Trading | ||
| Volume | 16,696,784 shares | US#92/3,112 Sec#4/269 |
| Trading Value | $3M | US#2,839/3,112 Sec#237/269 |
| Per Share | ||
| EPS | $-0.75 | US—/3,112 Sec—/269 |